Arie Belldegrun, Director at Allogene Therapeutics, Inc. (ALLO), bought 146,382 shares at $47.00 ($6.9M) on 2020-06-04, disclosed to the SEC on 2020-06-04.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.00 | 40,000 | $1.9M | 27.3% |
| 2 | $47.00 | 106,382 | $5.0M | 72.7% |
| Total | $47.00 avg | 146,382 | $6.9M | 100% |
| Filing → |
| ALLO | BUY | 2019-02-13 | $3.5M | — | Filing → |
| KITE | SELL | 2017-09-27 | $9.5M | — | Filing → |
| KITE | BUY | 2017-05-09 | $1.2M | — | Filing → |